UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1435) 1435
cefazolin - therapeutic use (1341) 1341
female (954) 954
science & technology (890) 890
life sciences & biomedicine (865) 865
male (860) 860
middle aged (634) 634
anti-bacterial agents - therapeutic use (612) 612
adult (581) 581
aged (473) 473
surgical wound infection - prevention & control (352) 352
cefazolin (351) 351
cefazolin - administration & dosage (350) 350
abridged index medicus (323) 323
cephalosporins - therapeutic use (310) 310
surgery (255) 255
animals (253) 253
antibiotics (242) 242
prospective studies (240) 240
antibiotic prophylaxis (214) 214
adolescent (212) 212
premedication (183) 183
retrospective studies (180) 180
staphylococcal infections - drug therapy (177) 177
microbial sensitivity tests (168) 168
anti-bacterial agents - administration & dosage (163) 163
treatment outcome (161) 161
pharmacology & pharmacy (157) 157
drug therapy, combination (153) 153
infectious diseases (149) 149
aged, 80 and over (148) 148
gentamicins - therapeutic use (145) 145
double-blind method (139) 139
risk factors (137) 137
cefazolin - pharmacology (132) 132
health aspects (131) 131
child (129) 129
vancomycin - therapeutic use (128) 128
microbiology (126) 126
clinical trials as topic (122) 122
time factors (120) 120
postoperative complications - prevention & control (117) 117
cefazolin - adverse effects (113) 113
bacterial infections - drug therapy (112) 112
random allocation (106) 106
bacterial infections - prevention & control (103) 103
ophthalmology (97) 97
pregnancy (95) 95
cefazolin - pharmacokinetics (92) 92
staphylococcus aureus (92) 92
orthopedics (91) 91
staphylococcus aureus - drug effects (91) 91
staphylococcal infections - microbiology (88) 88
child, preschool (84) 84
anti-bacterial agents - pharmacology (82) 82
antibiotic prophylaxis - methods (81) 81
infections (81) 81
injections, intravenous (80) 80
drug administration schedule (77) 77
ampicillin - therapeutic use (75) 75
general & internal medicine (75) 75
young adult (75) 75
cefazolin - blood (73) 73
eye infections, bacterial - drug therapy (73) 73
research article (73) 73
drug therapy, combination - therapeutic use (71) 71
infant (71) 71
surgical wound infection - epidemiology (71) 71
tobramycin - therapeutic use (68) 68
staphylococcal infections - prevention & control (64) 64
analysis (63) 63
medicine & public health (63) 63
medicine, general & internal (62) 62
staphylococcus aureus - isolation & purification (61) 61
surgical wound infection - microbiology (61) 61
peritonitis - drug therapy (60) 60
rabbits (59) 59
anti-bacterial agents - adverse effects (58) 58
corneal ulcer - drug therapy (58) 58
urology & nephrology (58) 58
rats (57) 57
vancomycin (57) 57
follow-up studies (56) 56
urinary tract infections - drug therapy (56) 56
ceftriaxone - therapeutic use (55) 55
cephalosporins - administration & dosage (55) 55
penicillins - therapeutic use (55) 55
research (54) 54
cefazolin - metabolism (53) 53
cephalosporins (53) 53
immunology (53) 53
infant, newborn (53) 53
mice (53) 53
biochemical phenomena, metabolism, and nutrition (52) 52
clindamycin - therapeutic use (52) 52
drug resistance, microbial (52) 52
obstetrics & gynecology (52) 52
patients (52) 52
infection (50) 50
pediatrics (50) 50
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1593) 1593
Japanese (53) 53
French (39) 39
German (34) 34
Russian (26) 26
Italian (24) 24
Spanish (21) 21
Portuguese (11) 11
Chinese (8) 8
Bulgarian (6) 6
Czech (3) 3
Hebrew (2) 2
Polish (2) 2
Danish (1) 1
Romanian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 02/2020, Volume 323, Issue 6, pp. 527 - 537
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 05/2012, Volume 56, Issue 5, pp. 2386 - 2391
Journal Article
Journal Article
JAMA surgery, ISSN 2168-6254, 12/2015, Volume 151, Issue 5, pp. 432 - 439
Journal Article
PloS one, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, pp. e37281 - e37281
... involve difficult therapeutic decisions leading to increased cost of additional treatments [7], [8]. Hence, in light of this socio-economic burden, there is a need... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Gentamicins - therapeutic use | Biofilms - growth & development | Pseudomonas Infections - complications | Rats | Male | Equipment Contamination | Staphylococcal Infections - complications | Anti-Bacterial Agents - therapeutic use | Animals | Staphylococcus epidermidis | Immunosuppression - adverse effects | Catheters, Indwelling - adverse effects | Models, Animal | Pseudomonas aeruginosa | Catheterization, Central Venous - adverse effects | Escherichia coli Infections - complications | Medical research | Medical equipment | Bacterial infections | Escherichia coli | Staphylococcus aureus infections | Medicine, Experimental | Cross infection | Nosocomial infections | Health aspects | Physiological apparatus | Staphylococcus aureus | Pediatrics | Surgical implants | Bioluminescence | Medical innovations | Disseminated infection | Clinical trials | Infections | Microorganisms | E coli | Bacteria | Pathogens | Medical devices | Stability | Complications | Medical instruments | Staphylococcus infections | Disease control | Contamination | Catheters | Biofilms | Antibiotics | Colonization | Index Medicus | Cefazolin/therapeutic use | Escherichia coli infections | Biofilms/growth & development | Central Venous/adverse effects | Life Sciences | Staphylococcal Infections/complications/drug therapy | Pseudomonas Infections/complications | Bloodstream infections | Immunosuppression/adverse effects | Bacterial biofilms | Gentamicins/therapeutic use | Catheterization | Indwelling/adverse effects | Escherichia coli Infections/complications | bacterial pathogens | Bacteriology | Microbiology and Parasitology | Animal | Models | Anti-Bacterial Agents/therapeutic use
Journal Article
Trials, ISSN 1745-6215, 03/2016, Volume 17, Issue 1, pp. 170 - 170
Background: Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia is a serious infection resulting in 20-50 % 90 day mortality. The limitations of... 
Flucloxacillin | Cefazolin | Methicillin-resistant | Combination | Daptomycin | MRSA | Randomised controlled trial | Vancomycin | Cloxacillin | Staphylococcus aureus | Nafcillin | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Singapore | Humans | Clinical Protocols | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Time Factors | Anti-Bacterial Agents - adverse effects | Staphylococcal Infections - microbiology | Drug Therapy, Combination | Methicillin Resistance | Cloxacillin - therapeutic use | Daptomycin - therapeutic use | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Methicillin-Resistant Staphylococcus aureus - drug effects | Treatment Outcome | Floxacillin - therapeutic use | New Zealand | Staphylococcal Infections - diagnosis | Vancomycin - therapeutic use | beta-Lactams - adverse effects | Israel | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Australia | beta-Lactams - therapeutic use | Research Design | Prevention | Drug resistance in microorganisms | Care and treatment | Analysis | Staphylococcus aureus infections | Clinical trials | Development and progression | Beta lactamases | Research | Health aspects | Index Medicus
Journal Article
Journal of oral and maxillofacial surgery, ISSN 0278-2391, 2011, Volume 69, Issue 8, pp. 2106 - 2111